|
Delayed
Nasdaq
12:48:22 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 10.28 USD | -3.20% |
|
-1.53% | +67.15% |
| 13/10 | ImmuCell Q3 Preliminary Sales Rise | MT |
| 13/10 | Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMUCELL CORPORATION | Other Pharmaceuticals | -3.20% | -1.53% | +67.15% | +70.48% | +16.82% | 96.45M |  |  | |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
